ePatient / Health 2.0 - A Key Factor for New and Innovative Business Models for the Life Sciences Industry

17 November 2011, Düsseldorf, Germany.
InterComponentWare AG (ICW), an internationally focused company specializing in technology solutions for the healthcare market, invites to a podium discussion during the Medica Media Forums. Follow the newest discussions at Medica 2011 in Düsseldorf and take advantage of the opportunity to discuss with subject matter experts. ICW representatives are looking forward to meeting you at 3:00 pm on Thursday, 17th November 2011 at the MEDICA Media Forum in Hall 15 (Stand A11).

Today's patients are well informed and capable of making their own decisions when it comes to healthcare. When making their decisions about health products and services they utilize both real-world channels and electronic channels of the internet. Increasingly, the "ePatient" is becoming a factor in the "Health 2.0 ecosystem".

ICW develops innovative solutions for the healthcare system under the slogan "connect. manage. personalize." Get a new perspective and discover how solutions from ICW can help you to network disparate actors, support care-critical processes, and create options for modern interaction to engage the patient in the treatment process.

Take time to visit ICW at MEDICA in Hall 15, Stand F35 to get an interesting look at modern eHealth solutions.

Arrange a personal appointment here: http://www.icw-global.com/en/press-events/medica-appointment.html, or send an email to Mr. Silvio Frey This email address is being protected from spambots. You need JavaScript enabled to view it.
Upon request ICW representatives will also gladly send complementary admission tickets or informational material.

About ICW
ICW is an international healthcare technology provider. Our robust software and techniologies help to network the various actors, optimize care and engage patients in the treatment process. Our products are based on the ICW eHealth Platform, a suite of powerful technology components that support the quick assembly of eHealth solutions and the flexible implementation of integration scenarios. Together with our partners, our goal is to enable interoperability among healthcare stakeholders to harvest potentials and realize innovative forms of cooperation and collaboration. For more information go to www.icw-global.com.

Most Popular Now

Delivering insulin in a pill

Given the choice of taking a pill or injecting oneself with a needle, most of us would opt to regulate a chronic health condition by swallowing a pill. But for millions o...

Probiotics can protect the skeletons of older wome…

For the first time in the world, researchers at the University of Gothenburg, Sweden, have demonstrated that probiotics, dietary supplements with health-promoting bacteri...

Alzheimer's breakthrough: Brain metals that may dr…

Alzheimer's disease could be better treated, thanks to a breakthrough discovery of the properties of the metals in the brain involved in the progression of the neurodegen...

FDA approves first drug comprised of an active ing…

The U.S. Food and Drug Administration today approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with two rare and severe forms o...

Can aspirin treat Alzheimer's?

A regimen of low-dose aspirin potentially may reduce plaques in the brain, which will reduce Alzheimer's disease pathology and protect memory, according to neurological r...

In mice, stem cells seem to work in fighting obesi…

Obesity is an increasing global health problem associated with several comorbidities and a high risk of mortality. A wide spectrum of interventions has been proposed for ...

FDA takes steps to foster greater efficiency in bi…

Today, the agency withdrew the draft guidance, "Statistical Approaches to Evaluate Analytical Similarity," issued in September 2017. The draft guidance, if finalized as w...

Research shows how a moderate dose of alcohol prot…

For at least 20 years, research has shown that for many people, moderate consumption of alcohol can protect the heart, but the reason for this is poorly understood. A stu...

'Kiss of death' cancer

It's called the 'kiss of death'. Triple negative breast cancer has no targeted drug therapy and, as such, the only hope for these patients is chemotherapy. Triple negativ...

Some existing anti-cancer drugs may act in part by…

Bolstering the notion that RNA should be considered an important drug-discovery target, scientists at Scripps Research have found that several existing, FDA-approved anti...

Novartis Clear about Psoriasis survey data highlig…

Novartis announced today the publication of global Clear about Psoriasis survey data in the Journal of the European Academy of Dermatology and Venereology[1]. The publica...

Poliovirus therapy for recurrent glioblastoma has …

A genetically modified poliovirus therapy developed at Duke Cancer Institute shows significantly improved long-term survival for patients with recurrent glioblastoma, wit...